'Pharma doesn't like fish oil': Wall Street funds sold Amarin after its big win

'Pharma doesn't like fish oil': Wall Street funds sold Amarin after its big win

STAT Plus: ‘Pharma doesn’t like fish oil’: Wall Street funds sold Amarin after big win with heart drug

By ADAM FEUERSTEIN

ADOBE

Wall Street fund managers lightened their stock positions in Amarin (AMRN) during the fourth quarter — an unexpected downshift in sentiment.

READ MORE